In yesterday’s Wall Street session, Cns Pharmaceuticals Inc (NASDAQ:CNSP) shares traded at $0.14, up 9.68% from the previous session.
CNSP stock price is now 1.31% away from the 50-day moving average and -98.20% away from the 200-day moving average. The market capitalization of the company currently stands at $4.85M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On August 24, 2020, Ladenburg Thalmann recently initiated its ‘Buy’ rating on the stock quoting a target price of $11
In other news, Gumulka Jerzy, Director bought 33,333 shares of the company’s stock on Feb 01 ’24. The stock was bought for $10,000 at an average price of $0.30. Upon completion of the transaction, the Director now directly owns 43,006 shares in the company, valued at $6020.84. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 01 ’24, Director Evans Carl Anthony bought 33,333 shares of the business’s stock. A total of $10,000 was incurred on buying the stock at an average price of $0.30. This leaves the insider owning 33,458 shares of the company worth $4684.12. A total of 1.81% of the company’s stock is owned by insiders.
During the past 12 months, Cns Pharmaceuticals Inc has had a low of $0.10 and a high of $137.50. The fifty day moving average price for CNSP is $0.14314 and a two-hundred day moving average price translates $8.060415 for the stock.
The latest earnings results from Cns Pharmaceuticals Inc (NASDAQ: CNSP) was released for 2024-06-30. The company reported revenue of $2.53 million for the quarter, compared to $4.03 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -37.19 percent.
